CDKN2A locus encodes two distinct proteins, p16INK4a and p14ARF, both of which demonstrate tumour suppressor activity in genetically distinct anticancer pathways: the 'Rb pathway' for p16INK4a and the 'p53 pathway' for p14ARF [Pubmed]